Literature DB >> 21056642

Synthesis of transferrin (Tf) conjugated liposomes via Staudinger ligation.

Songlin Xu1, Ying Liu, Heng-Chiat Tai, Jing Zhu, Hong Ding, Robert J Lee.   

Abstract

Staudinger ligation was evaluated as a strategy for synthesizing receptor targeted liposomes. First, an activated lipid derivative was synthesized by reacting dioleoyl phosphatidylethanolamine (DOPE) and 2-(diphenylphosphino) terephthalic acid 1-methyl 4-penta-fluorophenyldiester. Second, transferrin (Tf) was activated with p-azidophenyl isothiocyanate. Third, liposomes containing the activated lipid were prepared and then coupled to the activated Tf via the Staudinger reaction. These liposomes were evaluated in KB cells for cellular uptake and cytotoxicity, and in mice for pharmacokinetic properties. Tf-derivatized liposomes encapsulating calcein prepared by this conjugation method effectively targeted Tf receptor expressing KB cells. In addition, the Tf-targeted liposomes entrapping doxorubicin showed greatly enhanced in vitro cytotoxicity relative to non-targeted control liposomes. Pharmacokinetic parameters indicated that these liposomes retained long circulating properties relative to the free drug. In summary, Staudinger ligation is an effective method for the synthesis of receptor targeted liposomes.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21056642      PMCID: PMC3010482          DOI: 10.1016/j.ijpharm.2010.10.053

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  25 in total

1.  Incorporation of azides into recombinant proteins for chemoselective modification by the Staudinger ligation.

Authors:  Kristi L Kiick; Eliana Saxon; David A Tirrell; Carolyn R Bertozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

2.  pH-sensitive, serum-stable and long-circulating liposomes as a new drug delivery system.

Authors:  Myo-Sook Hong; Soo-Jeong Lim; Yu-Kyoung Oh; Chong-Kook Kim
Journal:  J Pharm Pharmacol       Date:  2002-01       Impact factor: 3.765

Review 3.  The transferrin receptor: role in health and disease.

Authors:  P Ponka; C N Lok
Journal:  Int J Biochem Cell Biol       Date:  1999-10       Impact factor: 5.085

4.  Enhanced pharmacodynamic and antitumor properties of a histone deacetylase inhibitor encapsulated in liposomes or ErbB2-targeted immunoliposomes.

Authors:  Daryl C Drummond; Corina Marx; Zexiong Guo; Gary Scott; Charles Noble; Donghui Wang; Maria Pallavicini; Dmitri B Kirpotin; Christopher C Benz
Journal:  Clin Cancer Res       Date:  2005-05-01       Impact factor: 12.531

5.  Targeted liposomes: convenient coupling of ligands to preformed vesicles using "click chemistry".

Authors:  Fatouma Said Hassane; Benoît Frisch; Francis Schuber
Journal:  Bioconjug Chem       Date:  2006 May-Jun       Impact factor: 4.774

Review 6.  Transferrin/transferrin receptor-mediated drug delivery.

Authors:  Hongyan Li; Zhong Ming Qian
Journal:  Med Res Rev       Date:  2002-05       Impact factor: 12.944

7.  Gamma-interferon modulates human monocyte/macrophage transferrin receptor expression.

Authors:  R Taetle; J M Honeysett
Journal:  Blood       Date:  1988-06       Impact factor: 22.113

8.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

9.  The MTT cell viability assay for cytotoxicity testing in multidrug-resistant human leukemic cells.

Authors:  D C Marks; L Belov; M W Davey; R A Davey; A D Kidman
Journal:  Leuk Res       Date:  1992-12       Impact factor: 3.156

10.  Cytotoxic effects of a doxorubicin-transferrin conjugate in multidrug-resistant KB cells.

Authors:  M Fritzer; T Szekeres; V Szüts; H N Jarayam; H Goldenberg
Journal:  Biochem Pharmacol       Date:  1996-02-23       Impact factor: 5.858

View more
  8 in total

1.  CD33-Targeted Lipid Nanoparticles (aCD33LNs) for Therapeutic Delivery of GTI-2040 to Acute Myelogenous Leukemia.

Authors:  Hong Li; Songlin Xu; Jishan Quan; Bryant C Yung; Jiuxia Pang; Chenguang Zhou; Young-Ah Cho; Mengzi Zhang; Shujun Liu; Natarajan Muthusamy; Kenneth K Chan; John C Byrd; L James Lee; Guido Marcucci; Robert J Lee
Journal:  Mol Pharm       Date:  2015-04-28       Impact factor: 4.939

Review 2.  The transferrin receptor and the targeted delivery of therapeutic agents against cancer.

Authors:  Tracy R Daniels; Ezequiel Bernabeu; José A Rodríguez; Shabnum Patel; Maggie Kozman; Diego A Chiappetta; Eggehard Holler; Julia Y Ljubimova; Gustavo Helguera; Manuel L Penichet
Journal:  Biochim Biophys Acta       Date:  2011-08-05

3.  Transferrin-targeted polymeric micelles co-loaded with curcumin and paclitaxel: efficient killing of paclitaxel-resistant cancer cells.

Authors:  Abraham H Abouzeid; Niravkumar R Patel; Can Sarisozen; Vladimir P Torchilin
Journal:  Pharm Res       Date:  2014-02-13       Impact factor: 4.200

4.  A microfluidic method to synthesize transferrin-lipid nanoparticles loaded with siRNA LOR-1284 for therapy of acute myeloid leukemia.

Authors:  Zhaogang Yang; Bo Yu; Jing Zhu; Xiaomeng Huang; Jing Xie; Songlin Xu; Xiaojuan Yang; Xinmei Wang; Bryant C Yung; L James Lee; Robert J Lee; Lesheng Teng
Journal:  Nanoscale       Date:  2014-07-08       Impact factor: 7.790

5.  A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood-brain barrier, and the transporting mechanism to glioma cells.

Authors:  Chang Liu; Xiao-Na Liu; Gui-Ling Wang; Yu Hei; Shuai Meng; Ling-Fei Yang; Lan Yuan; Ying Xie
Journal:  Int J Nanomedicine       Date:  2017-03-28

6.  Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma.

Authors:  Xiaoju Zhou; Mengzi Zhang; Bryant Yung; Hong Li; Chenguang Zhou; L James Lee; Robert J Lee
Journal:  Int J Nanomedicine       Date:  2012-10-16

7.  A Novel Isoquinoline Derivative Anticancer Agent and Its Targeted Delivery to Tumor Cells Using Transferrin-Conjugated Liposomes.

Authors:  Xuewei Yang; Shuang Yang; Hongyu Chai; Zhaogang Yang; Robert J Lee; Weiwei Liao; Lesheng Teng
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

8.  Non-viral liposome-mediated transfer of brain-derived neurotrophic factor across the blood-brain barrier.

Authors:  Ying Xing; Chun-Yan Wen; Song-Tao Li; Zong-Xin Xia
Journal:  Neural Regen Res       Date:  2016-04       Impact factor: 5.135

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.